NOV120101 (Poziotinib) for 1st Line Monotherapy in Patients With Lung Adenocarcinoma

Clinical trial NCT01819428 · TERMINATED

Trial details

NCT number: NCT01819428
Sponsor: National OncoVenture
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma of Lung Stage IIIB Adenocarcinoma of Lung Stage IV

Start date: 2013-03-01
Primary completion: 2015-11-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.